Şunu aradınız:: specification (İtalyanca - Fransızca)

wavelet scalar quantization grayscale fingerprint image compression specification
wavelet scalar quantization grayscale fingerprint image compression specification

41 | riservato unisig subset 028 | jru test specification | |
41 | réservé unisig subset-028 | jru test specification | |

« exchange specification for the n13 phase ii data exchange system » .
« exchange specification for the n13 phase ii data exchange system » .

the food industry development scheme (specification of activities) order 1997
the food industry development scheme (specification of activities) order 1997

48 | riservato | test specification for mobile equipment gsm-r | |
48 | réservé | test specification for mobile equipment gsm-r | |

note for guidance on specification limits for residues of heavy metal catalysts in medicinal products
note for guidance on specification limits for residues of heavy metal catalysts in medicinal products

se ti interessa saperne di più sui bridge da un punto di vista tecnico, leggi la tor bridges specification .
si vous voulez en savoir plus sur le design des passerelles d'un point de vue plus technique, voyez les spécifications de passerelles tor .

in inglese (number of kilograms, in letters and figures) not in accordance with specification …
en anglais (number of kilograms, in letters and figures) not in accordance with specification …

a simple and elegant solution to this problem is to add 2>/dev/null at the end of the command specification.
ktimemon est basée sur une version de xt de mon frère.

note for guidance on photosafety testing note for guidance on specification limits for residues of metal catalysts swp conclusions and recommendations with regard to the use of genetically modified animal models for carcinogenicity assessment
note for guidance on photosafety testing note for guidance on specification limits for residues of metal catalysts swp conclusions and recommendations with regard to the use of genetically modified animal models for carcinogenicity assessment

accordingly, the invitations to austria refer to the specification of the budgetary strategy to correct the excessive deficit and reduce debt, and improvements to the fiscal framework.
l’autriche est, en conséquence, invitée à préciser la stratégie budgétaire qui lui permettra de corriger son déficit excessif et de réduire sa dette et à améliorer son cadre budgétaire.

the invitations to belgium concern the specification of the budgetary strategy to correct the excessive deficit and reduce debt, and improvements to long-term sustainability and the fiscal framework.
la belgique est invitée à préciser la stratégie budgétaire qui lui permettra de corriger son déficit excessif et de réduire sa dette, à améliorer la viabilité de ses finances publiques à long terme et à renforcer son cadre budgétaire.

altre pubblicazioni dell' ime 21 « the single monetary policy in stage three - specification of the operational framework » , gennaio 1997 , trad .
autres documents publiés par l' ime21 « the single monetary policy in stage three - specification of the operational framework » , janvier 1997 .

63) note for guidance on photosafety testing points to consider document on the need for assessment of reproductive toxicity of human insulin analogues discussion paper on environmental risk assessments of non-gmo containing medicinal products for human use non-clinical documentation of medicinal products with ‘ well-established use’ note for guidance on the need for non-clinical testing of pharmaceuticals in juvenile animals discussion paper on the non-clinical safety studies to support single low dose clinical screening studies in man note for guidance on specification limits for residues for heavy metal catalysts in medicinal products points to consider on xenogeneic cell therapy note for guidance on comparability of biotechnology products pre-clinical and clinical issues points to consider on the assessment of the potential for qt interval prolongation by non-cardiovascular medicinal products note for guidance on risk assessment of medicinal products on human reproductive and development toxicities: from data to labelling
63) note for guidance on photosafety testing points to consider document on the need for assessment of reproductive toxicity of human insulin analogues discussion paper on environmental risk assessments of non-gmo containing medicinal products for human use non-clinical documentation of medicinal products with ‘ well-established use 'note for guidance on the need for non-clinical testing of pharmaceuticals in juvenile animals discussion paper on the non-clinical safety studies to support single low dose clinical screening studies in man note for guidance on specification limits for residues for heavy metal catalysts in medicinal products points to consider on xenogeneic cell therapy note for guidance on comparability of biotechnology products pre-clinical and clinical issues points to consider on the assessment of the potential for qt interval prolongation by non-cardiovascular medicinal products note for guidance on risk assessment of medicinal products on human reproductive and development toxicities: from data to labelling